38 related articles for article (PubMed ID: 24092938)
1. Radiation dose of the P-glycoprotein tracer 11C-laniquidar.
Postnov A; Froklage FE; van Lingen A; Reijneveld JC; Hendrikse NH; Windhorst AD; Schuit RC; Eriksson J; Lammertsma AA; Huisman MC
J Nucl Med; 2013 Dec; 54(12):2101-3. PubMed ID: 24092938
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats.
Luurtsema G; Schuit RC; Klok RP; Verbeek J; Leysen JE; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2009 Aug; 36(6):643-9. PubMed ID: 19647170
[TBL] [Abstract][Full Text] [Related]
3. Quantification of 11C-Laniquidar Kinetics in the Brain.
Froklage FE; Boellaard R; Bakker E; Hendrikse NH; Reijneveld JC; Schuit RC; Windhorst AD; Schober P; van Berckel BN; Lammertsma AA; Postnov A
J Nucl Med; 2015 Nov; 56(11):1730-5. PubMed ID: 26294297
[TBL] [Abstract][Full Text] [Related]
4. The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier.
Moerman L; Dumolyn C; Boon P; De Vos F
Nucl Med Biol; 2012 Jan; 39(1):121-5. PubMed ID: 21958857
[TBL] [Abstract][Full Text] [Related]
5. [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Syvänen S; Russmann V; Verbeek J; Eriksson J; Labots M; Zellinger C; Seeger N; Schuit R; Rongen M; van Kooij R; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA; Koepp M; Potschka H
Nucl Med Biol; 2013 Aug; 40(6):764-75. PubMed ID: 23827307
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.
Kurdziel KA; Kiesewetter DO; Carson RE; Eckelman WC; Herscovitch P
J Nucl Med; 2003 Aug; 44(8):1330-9. PubMed ID: 12902425
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET.
Kawamura K; Konno F; Yui J; Yamasaki T; Hatori A; Yanamoto K; Wakizaka H; Takei M; Nengaki N; Fukumura T; Zhang MR
Ann Nucl Med; 2010 Jun; 24(5):403-12. PubMed ID: 20361276
[TBL] [Abstract][Full Text] [Related]
8. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
[TBL] [Abstract][Full Text] [Related]
9. Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans.
Bauer M; Blaickner M; Philippe C; Wadsak W; Hacker M; Zeitlinger M; Langer O
J Nucl Med; 2016 Aug; 57(8):1265-8. PubMed ID: 27081167
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
Elsinga PH; Franssen EJ; Hendrikse NH; Fluks L; Weemaes AM; van der Graaf WT; de Vries EG; Visser GM; Vaalburg W
J Nucl Med; 1996 Sep; 37(9):1571-5. PubMed ID: 8790221
[TBL] [Abstract][Full Text] [Related]
12. 18F-ML-10, a PET tracer for apoptosis: first human study.
Höglund J; Shirvan A; Antoni G; Gustavsson SÅ; Långström B; Ringheim A; Sörensen J; Ben-Ami M; Ziv I
J Nucl Med; 2011 May; 52(5):720-5. PubMed ID: 21498526
[TBL] [Abstract][Full Text] [Related]
13. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
14. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
15. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 11C-colchicine for PET imaging of multiple drug resistance.
Levchenko A; Mehta BM; Lee JB; Humm JL; Augensen F; Squire O; Kothari PJ; Finn RD; Leonard EF; Larson SM
J Nucl Med; 2000 Mar; 41(3):493-501. PubMed ID: 10716325
[TBL] [Abstract][Full Text] [Related]
17. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
18. Whole-body distribution and radiation dosimetry of 11C-(+)-PHNO, a D2/3 agonist ligand.
Mizrahi R; Rusjan P; Vitcu I; Ng A; Wilson AA; Houle S; Bloomfield PM
J Nucl Med; 2012 Nov; 53(11):1802-6. PubMed ID: 22967806
[TBL] [Abstract][Full Text] [Related]
19. Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.
Ahmad R; Koole M; Evens N; Serdons K; Verbruggen A; Bormans G; Van Laere K
Mol Imaging Biol; 2013 Aug; 15(4):384-90. PubMed ID: 23508466
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose estimates for carbon-11-labelled PET tracers.
van der Aart J; Hallett WA; Rabiner EA; Passchier J; Comley RA
Nucl Med Biol; 2012 Feb; 39(2):305-14. PubMed ID: 22033023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
